Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma

G. Holló, Auli Ropo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We investigated the intraocular pressure (IOP) lowering efficacy of preservative-free fixed and non-fixed combination of tafluprost 0.0015% and timolol 0.5% in pseudoexfoliative glaucoma (XFG). A per protocol worse eye analysis was made on all XFG patients who participated in a recent 6 month, prospective, randomized, double-masked, parallel group, multicenter phase III study. The mean time-wise IOP decreased by 8.62 to 10.25 mmHg (31.8 to 36.7%) in the fixed dose combination arm (15 patients) and by 5.38 to 11.35 mmHg (21.3 to 41.2%) in the non-fixed combination arm (13 patients), respectively (p <0.001 for all comparisons). The results show that a preservative-free fixed dose combination of tafluprost and timolol provides a clinically significant IOP reduction in XFG, and may offer an advantage for the XFG patients with dry eye, due to its preservative-free nature.

Original languageEnglish
Article number972500
Pages (from-to)13-16
Number of pages4
JournalCurrent Medical Research and Opinion
Volume31
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Timolol
Intraocular Pressure
Glaucoma
Arm
tafluprost

Keywords

  • Intraocular pressure
  • Preservative free topical medication
  • Pseudoexfoliative glaucoma
  • Tafluprost/timolol fixed combination

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{d524d78abdf84123928f5d4eb5d01edc,
title = "Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma",
abstract = "We investigated the intraocular pressure (IOP) lowering efficacy of preservative-free fixed and non-fixed combination of tafluprost 0.0015{\%} and timolol 0.5{\%} in pseudoexfoliative glaucoma (XFG). A per protocol worse eye analysis was made on all XFG patients who participated in a recent 6 month, prospective, randomized, double-masked, parallel group, multicenter phase III study. The mean time-wise IOP decreased by 8.62 to 10.25 mmHg (31.8 to 36.7{\%}) in the fixed dose combination arm (15 patients) and by 5.38 to 11.35 mmHg (21.3 to 41.2{\%}) in the non-fixed combination arm (13 patients), respectively (p <0.001 for all comparisons). The results show that a preservative-free fixed dose combination of tafluprost and timolol provides a clinically significant IOP reduction in XFG, and may offer an advantage for the XFG patients with dry eye, due to its preservative-free nature.",
keywords = "Intraocular pressure, Preservative free topical medication, Pseudoexfoliative glaucoma, Tafluprost/timolol fixed combination",
author = "G. Holl{\'o} and Auli Ropo",
year = "2015",
month = "1",
day = "1",
doi = "10.1185/03007995.2014.972500",
language = "English",
volume = "31",
pages = "13--16",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma

AU - Holló, G.

AU - Ropo, Auli

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We investigated the intraocular pressure (IOP) lowering efficacy of preservative-free fixed and non-fixed combination of tafluprost 0.0015% and timolol 0.5% in pseudoexfoliative glaucoma (XFG). A per protocol worse eye analysis was made on all XFG patients who participated in a recent 6 month, prospective, randomized, double-masked, parallel group, multicenter phase III study. The mean time-wise IOP decreased by 8.62 to 10.25 mmHg (31.8 to 36.7%) in the fixed dose combination arm (15 patients) and by 5.38 to 11.35 mmHg (21.3 to 41.2%) in the non-fixed combination arm (13 patients), respectively (p <0.001 for all comparisons). The results show that a preservative-free fixed dose combination of tafluprost and timolol provides a clinically significant IOP reduction in XFG, and may offer an advantage for the XFG patients with dry eye, due to its preservative-free nature.

AB - We investigated the intraocular pressure (IOP) lowering efficacy of preservative-free fixed and non-fixed combination of tafluprost 0.0015% and timolol 0.5% in pseudoexfoliative glaucoma (XFG). A per protocol worse eye analysis was made on all XFG patients who participated in a recent 6 month, prospective, randomized, double-masked, parallel group, multicenter phase III study. The mean time-wise IOP decreased by 8.62 to 10.25 mmHg (31.8 to 36.7%) in the fixed dose combination arm (15 patients) and by 5.38 to 11.35 mmHg (21.3 to 41.2%) in the non-fixed combination arm (13 patients), respectively (p <0.001 for all comparisons). The results show that a preservative-free fixed dose combination of tafluprost and timolol provides a clinically significant IOP reduction in XFG, and may offer an advantage for the XFG patients with dry eye, due to its preservative-free nature.

KW - Intraocular pressure

KW - Preservative free topical medication

KW - Pseudoexfoliative glaucoma

KW - Tafluprost/timolol fixed combination

UR - http://www.scopus.com/inward/record.url?scp=84918809773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918809773&partnerID=8YFLogxK

U2 - 10.1185/03007995.2014.972500

DO - 10.1185/03007995.2014.972500

M3 - Article

VL - 31

SP - 13

EP - 16

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 1

M1 - 972500

ER -